Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies

相似書籍

• Up-regulation of IGF-1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small molecule inhibition of IGF-1R
  由: Weisberg, Ellen, et al.
  出版: (2014)
• Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells
  由: Weisberg, Ellen, et al.
  出版: (2013)
• Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach
  由: Nonami, Atsushi, et al.
  出版: (2015)
• FLT3 Inhibition and Mechanisms of Drug Resistance in mutant FLT3-Positive AML
  由: Weisberg, Ellen, et al.
  出版: (2009)
• Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: Synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors, and JAK inhibitors: Novel combination therapy approaches to overriding stromal-mediated chemoresistance
  由: Weisberg, Ellen, et al.
  出版: (2012)